Castle Biosciences, Inc.
CSTL
$24.06
$0.502.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.47M | -5.07M | 18.25M | 6.08M | -3.10M |
| Total Depreciation and Amortization | 42.49M | 42.42M | 16.00M | 13.45M | 13.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.58M | 44.02M | 44.75M | 48.00M | 42.80M |
| Change in Net Operating Assets | -9.11M | -15.71M | -14.13M | -8.44M | -12.02M |
| Cash from Operations | 62.49M | 65.67M | 64.87M | 59.09M | 40.76M |
| Capital Expenditure | -27.95M | -23.91M | -28.33M | -24.55M | -20.63M |
| Sale of Property, Plant, and Equipment | 32.00K | 22.00K | 18.00K | 14.00K | 12.00K |
| Cash Acquisitions | -18.73M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.19M | -28.98M | -21.83M | -39.04M | -37.88M |
| Cash from Investing | -59.83M | -52.87M | -50.14M | -63.58M | -58.50M |
| Total Debt Issued | 0.00 | 0.00 | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -107.00K | -87.00K | -97.00K | -107.00K | -119.00K |
| Issuance of Common Stock | 4.70M | 4.83M | 5.00M | 4.73M | 2.93M |
| Repurchase of Common Stock | -10.78M | -10.80M | -8.76M | -6.40M | -5.38M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 190.00K | -- | -- | -- | -- |
| Cash from Financing | -6.00M | -6.06M | 6.14M | 8.23M | 7.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.34M | 6.74M | 20.87M | 3.74M | -10.30M |